These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35645733)

  • 1. Gene and Cell Therapy for Epilepsy: A Mini Review.
    Shaimardanova AA; Chulpanova DS; Mullagulova AI; Afawi Z; Gamirova RG; Solovyeva VV; Rizvanov AA
    Front Mol Neurosci; 2022; 15():868531. PubMed ID: 35645733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multipronged Attack of Stem Cell Therapy in Treating the Neurological and Neuropsychiatric Symptoms of Epilepsy.
    Sadanandan N; Saft M; Gonzales-Portillo B; Borlongan CV
    Front Pharmacol; 2021; 12():596287. PubMed ID: 33815100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Therapy in Treating Epilepsy.
    Chang BL; Chang KH
    Front Neurosci; 2022; 16():934507. PubMed ID: 35833086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concise Review: Prospects of Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells for Treating Status Epilepticus and Chronic Epilepsy.
    Agadi S; Shetty AK
    Stem Cells; 2015 Jul; 33(7):2093-103. PubMed ID: 25851047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adeno-Associated Virus-Mediated Overexpression of Interleukin-10 Affects the Immunomodulatory Properties of Equine Bone Marrow-Derived Mesenchymal Stem Cells.
    Cameron AD; Even KM; Linardi RL; Berglund AK; Schnabel LV; Engiles JB; Ortved KF
    Hum Gene Ther; 2021 Sep; 32(17-18):907-918. PubMed ID: 33843261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefits of single vs repeated courses of mesenchymal stem cell therapy in epilepsy patients.
    Hlebokazov F; Dakukina T; Potapnev M; Kosmacheva S; Moroz L; Misiuk N; Golubeva T; Slobina E; Krasko O; Shakhbazau A; Hlavinski I; Goncharova N
    Clin Neurol Neurosurg; 2021 Aug; 207():106736. PubMed ID: 34119901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple Autologous Bone Marrow-Derived CD271
    Milczarek O; Jarocha D; Starowicz-Filip A; Kwiatkowski S; Badyra B; Majka M
    Stem Cells Transl Med; 2018 Jan; 7(1):20-33. PubMed ID: 29224250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current regenerative medicine-based approaches for skin regeneration: A review of literature and a report on clinical applications in Japan.
    Shimizu Y; Ntege EH; Sunami H
    Regen Ther; 2022 Dec; 21():73-80. PubMed ID: 35785041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem Cell Mimicking Nanoencapsulation for Targeting Arthritis.
    Shin MJ; Park JY; Lee DH; Khang D
    Int J Nanomedicine; 2021; 16():8485-8507. PubMed ID: 35002240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
    Glavaski-Joksimovic A; Virag T; Mangatu TA; McGrogan M; Wang XS; Bohn MC
    J Neurosci Res; 2010 Sep; 88(12):2669-81. PubMed ID: 20544825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficiency of bone marrow-derived mesenchymal stem cells for liver fibrosis: A systematic review of
    Al-Dhamin Z; Liu LD; Li DD; Zhang SY; Dong SM; Nan YM
    World J Gastroenterol; 2020 Dec; 26(47):7444-7469. PubMed ID: 33384547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of Neurotrophic Effects of Mesenchymal Stem Cells Derived from Different Tissues on Chronic Spinal Cord Injury Rats.
    Otsuka T; Maeda Y; Kurose T; Nakagawa K; Mitsuhara T; Kawahara Y; Yuge L
    Stem Cells Dev; 2021 Sep; 30(17):865-875. PubMed ID: 34148410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hUC-MSC-mediated recovery of subacute spinal cord injury through enhancing the pivotal subunits β3 and γ2 of the GABA
    Cao T; Chen H; Huang W; Xu S; Liu P; Zou W; Pang M; Xu Y; Bai X; Liu B; Rong L; Cui ZK; Li M
    Theranostics; 2022; 12(7):3057-3078. PubMed ID: 35547766
    [No Abstract]   [Full Text] [Related]  

  • 16. Contemplating stem cell therapy for epilepsy-induced neuropsychiatric symptoms.
    Rao G; Mashkouri S; Aum D; Marcet P; Borlongan CV
    Neuropsychiatr Dis Treat; 2017; 13():585-596. PubMed ID: 28260906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term, Targeted Delivery of GDNF from Encapsulated Cells Is Neuroprotective and Reduces Seizures in the Pilocarpine Model of Epilepsy.
    Paolone G; Falcicchia C; Lovisari F; Kokaia M; Bell WJ; Fradet T; Barbieri M; Wahlberg LU; Emerich DF; Simonato M
    J Neurosci; 2019 Mar; 39(11):2144-2156. PubMed ID: 30665947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic and neuro-protective potential of a novel subpopulation of peripheral blood-derived CD133+ ABCG2+CXCR4+ mesenchymal stem cells: development of autologous cell-based therapeutics for traumatic brain injury.
    Nichols JE; Niles JA; DeWitt D; Prough D; Parsley M; Vega S; Cantu A; Lee E; Cortiella J
    Stem Cell Res Ther; 2013 Jan; 4(1):3. PubMed ID: 23290300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/stromal cell therapy for pulmonary arterial hypertension: Comprehensive review of preclinical studies.
    Fukumitsu M; Suzuki K
    J Cardiol; 2019 Oct; 74(4):304-312. PubMed ID: 31109735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases.
    Kan I; Melamed E; Offen D
    Handb Exp Pharmacol; 2007; (180):219-42. PubMed ID: 17554511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.